ILT5/CD85a/LILRB3 Antibody (4F9), DyLight 680, Novus Biologicals™

ILT5/CD85a/LILRB3

Monoclonal

DyLight 680

50mM Sodium Borate with 0.05% Sodium Azide

LILRB3

Monocyte derived dendritic cells

0.1 mL

Primary

NB100-64329 is specific for human CD85a (leucocyte immunoglobulin-like receptor, subfamily B, member 3/ LILRB3), also known as ILT-5, expressed by monocytes, dendritic cells, macrophages, subpopulation of T lymphocytes, B cells and at high levels on plasma cells. CD85a is a 631 amino acid type I transmembrane glycoprotein, which contains four immunoreceptor tyrosine-based inhibition motif (ITIM) sequences within a long cytoplasmic tail. Phosphorylation of the tyrosine residues within ITIMs is known to enable the binding and activation of protein tyrosine phosphatases, which act as cell signalling modulators and inhibitors of cell activation.

Store at 4C in the dark.

IgG1

Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Frozen)

4F9

Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Frozen

CD85 antigen-like family member A, CD85a antigen, HL9Immunoglobulin-like transcript 5, ILT-5, ILT5CD85a, Leukocyte immunoglobulin-like receptor 3, leukocyte immunoglobulin-like receptor subfamily B member 3, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR3CD85A, LIR-3MGC138403, member 3, Monocyte inhibitory receptor HL9, PIRB

Mouse

Protein G purified

RUO

11025

Human

Purified